Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Walgreens Boots Alliance (WBA) Stock Price
Media headlines about Walgreens Boots Alliance (NASDAQ:WBA) have trended somewhat positive on Saturday, Accern reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Walgreens Boots Alliance earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave press coverage about the pharmacy operator an impact score of 46.5522477575009 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the media headlines that may have effected Accern Sentiment’s analysis:
- Cisco Disappoints as Tech Lags; Walgreens-Rite Aid Test FTC Again — ICYMI (finance.yahoo.com)
- Walgreens Boots to Gain From Altered Rite Aid Deal, Alliance – Yahoo Finance (finance.yahoo.com)
- Will Walgreens Ever Get to Spend $5.2 Billion on 2,186 Rite Aid Stores? (finance.yahoo.com)
- Say ‘yes’ to every opportunity if you want to advance your career, says former Walgreens CEO (finance.yahoo.com)
- Will the FTC Let Walgreens Go on a $5.2 Billion Rite Aid Shopping Spree? (finance.yahoo.com)
A number of equities research analysts recently commented on WBA shares. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. Jefferies Group LLC reduced their target price on shares of Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, May 31st. Needham & Company LLC began coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, June 27th. They issued a “hold” rating on the stock. Credit Suisse Group reissued a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Finally, Leerink Swann set a $86.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Friday, July 7th. Two analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus target price of $90.69.
Shares of Walgreens Boots Alliance (NASDAQ WBA) traded down 1.06% during trading on Friday, reaching $80.03. 5,239,292 shares of the company’s stock were exchanged. Walgreens Boots Alliance has a 12-month low of $75.18 and a 12-month high of $89.69. The company has a market capitalization of $85.64 billion, a P/E ratio of 20.21 and a beta of 1.25. The stock has a 50-day moving average price of $79.60 and a 200 day moving average price of $82.28.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. During the same quarter in the previous year, the business earned $1.18 earnings per share. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. Equities analysts expect that Walgreens Boots Alliance will post $5.00 EPS for the current fiscal year.
Walgreens Boots Alliance announced that its Board of Directors has authorized a stock buyback program on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date is Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s payout ratio is 40.30%.
In other news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 13.50% of the stock is owned by corporate insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.